Company / Operating Cash Flow per Share
Nuvalent, Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$3.79
FY2025
5-year range
-$3.79 / -$1.31
FY2021-FY2025
Trend
-35.9%
vs FY2024
Sector context
#185 of 212
Health Care
What the data says
Nuvalent, Inc.'s operating cash flow per share of $-3.79 is lower than 87% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has declined for 3 consecutive years, from $-1.31 in FY2022 to $-3.79 in FY2025.
Based on SEC 10-K filings.
-3.79 in FY2025.
Declined from $-1.71 to $-3.79 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 212This company -$3.79 Sector average -$14.72
▼
+74.3% above sector average
Key checks
Key Insights
- Nuvalent, Inc.'s operating cash flow per share has declined for 3 consecutive years.
- In FY2025, operating cash flow per share decreased 35.9% year-over-year.
- Ranks #185 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.79 | -35.9% |
| FY2024 | -$2.79 | -62.7% |
| FY2023 | -$1.71 | -31.0% |
| FY2022 | -$1.31 | +28.8% |
| FY2021 | -$1.84 | +64.8% |
| FY2020 | -$5.21 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026